ULBI

Ultralife Corporation
NASDAQINDUSTRIALSELECTRICAL EQUIPMENT & PARTS

Key Statistics

Market Cap
$121.14M
P/E Ratio
EPS
$-0.38
Beta
0.80
52W High
$8.25
52W Low
$4.90
50-Day MA
$6.06
200-Day MA
$6.25
Dividend Yield
Profit Margin
-3.50%
Forward P/E
15.34
PEG Ratio
3.81

About Ultralife Corporation

Ultralife Corporation designs, manufactures, installs and maintains electrical, communication and electronic systems worldwide. The company is headquartered in Newark, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$187.24M
Gross Profit (TTM)$45.65M
EBITDA$12.73M
Operating Margin9.01%
Return on Equity-4.91%
Return on Assets2.10%
Revenue/Share (TTM)$11.24
Book Value$7.78
Price-to-Book0.94
Price-to-Sales (TTM)0.65
EV/Revenue0.868
EV/EBITDA149.65
Quarterly Earnings Growth (YoY)200.00%
Quarterly Revenue Growth (YoY)-1.30%
Shares Outstanding$16.66M
Float$9.62M
% Insiders3.22%
% Institutions73.89%

Historical Volatility

HV 10-Day
98.34%
HV 20-Day
75.39%
HV 30-Day
67.75%
HV 60-Day
61.95%
HV Rank
83.7%

Volatility is currently expanding

Latest News

Ultralife Q2 Earnings Call Highlights

Ultralife NASDAQ: ULBI reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications businesses.

MarketBeat8/7/2026Positive
Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: Sales of $47.9 million compared to $48.6 million for the 2025 second quarter Gross profit of $13.9 million, or 28.9% of revenue, compared to $11.6 million, or 23.9% of revenue, for the 2025 second quarter; excluding a $1.1 million net IEEPA refund received in the 2026 second quarter, gross margin was 26.6% Operating income of $3.4 million, including one-time costs of $0.9 million, compared to $2.3 million including one-time costs of $0.3 million for the 2025 second quarter GAAP EPS of $0.15 compared to $0.05 for the 2025 second quarter Adjusted EBITDA of $6.1 million compared to $4.1 million for the 2025 second quarter Backlog of $117.5 million compared to $115.1 million exiting the first quarter of 2026 “For the second quarter we delivered a 760-basis point improvement in gross profit margin compared to the first quarter, including the contribution of the net IEEPA refund.

GlobeNewsWire8/7/2026Neutral
Zacks Initiates Coverage of Ultralife With Underperform Recommendation

Discover why Zacks rates Ultralife as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore ULBI's struggles with execution risks, margin pressure and commercialization delays that could delay its earnings recovery.

Zacks Investment Research7/16/2026Negative
Ultralife Q1 Earnings Call Highlights

Ultralife NASDAQ: ULBI reported a first-quarter loss for fiscal 2026 as lower sales, production disruptions and higher one-time costs weighed on results, even as management pointed to a record backlog and new product activity as signs of future growth.

MarketBeat5/9/2026Negative

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ULBI and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More INDUSTRIALS Stocks

Data last updated: 8/18/2026